Aptameric nanobiosensors for the diagnosis of COVID-19: An update

14Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

COVID-19 pandemic has left a catastrophic effect on the world economy and human civilization. As an effective step towards controlling the transmission of viral infections during multiple waves of COVID-19, there is an urgent need to develop robust nanobiosensors for the detection of SARS-CoV-2 with high sensitivity, specificity, and fast analysis. Aptameric nanobiosensors are rapid and sensitive diagnostic platforms, capable of SARS-CoV-2 detection, which overcomes the limitations of the conventional techniques. This review article presents an outline of the aptameric nanobiosensors established for improved diagnosis of SARS-CoV-2 and the future perspectives are also covered.

Cite

CITATION STYLE

APA

Krishnan, S., Kumar Narasimhan, A., Gangodkar, D., Dhanasekaran, S., Kumar Jha, N., Dua, K., … Kumar Gupta, P. (2022). Aptameric nanobiosensors for the diagnosis of COVID-19: An update. Materials Letters, 308. https://doi.org/10.1016/j.matlet.2021.131237

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free